The single-cell analysis revealed a diverse range of cell types within the tumor microenvironment (TME), including tumor cells, immune cells, and fibroblasts, with varying proportions across cases.

Background Differentiating arteritic anterior ischaemic optic neuropathy (A-AION) due to giant cell arteritis (GCA) from non-arteritic anterior ischaemic ... Two radiologists blinded to clinical data ...

Objectives Clinical management of giant cell arteritis (GCA) involves balancing the risks and burdens arising from the disease with those arising from treatment, but there is little research on the ...

uses to traverse the inner and outer layers of skin and emerge onto the skin's surface. The study identifies new cell types within the skin ...

AIM Ocular involvement in giant cell arteritis (GCA) is an ophthalmic emergency which, if untreated, can progress to permanent blindness. There is little evidence in the literature to support current ...

Abbreviations: MPNST, malignant peripheral nerve sheath tumor; ID, identification number; NF1, neurofibromatosis type 1; M, male; DFD, dead from disease; F, female ...

Our result are similar to those published in the laiterature. Abnormal temporal arteries on physical examination may help to diagnosis Reference [1] Utility of Erithrocyte sedimentation rate and ...

However, their effectiveness has plateaued due to therapeutic resistance that renders tumor-infiltrating lymphocytes ... Additionally, pharmacologic inhibition of T cell glycolysis under hypoxia ...

Tumors can appear anywhere on a dog’s body, including internally or on the skin. They can look like a small bump or they can appear as a giant mass, bulging out of your dog’s body. Tsang notes ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

Tumors are the result of abnormal cell growth. Usually, the cells in your body grow and divide to form new cells whenever your body needs them. When older cells die, they’re replaced by new ones.

Selumetinib sulfate is under clinical development by AstraZeneca and currently in Phase II for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma ... relapsed or refractory diffuse large B-cell lymphoma ...